Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **greater splanchnic nerve** is a major component of the thoracic splanchnic nerves, arising from the medial branches of the fifth through ninth thoracic sympathetic ganglia. It descends along the anterior surface of the spine, passes through the diaphragm, and terminates primarily at the celiac ganglia. The greater splanchnic nerve carries preganglionic sympathetic fibers that provide autonomic innervation to foregut structures including the liver, gallbladder, spleen, stomach, pancreas, duodenum, and also sends fibers to stimulate catecholamine release from the adrenal medulla. Its main functions are modulation of visceral activity—such as inhibiting gut motility and secretions—and regulation of vascular tone within its target organs[1][2][3][5]. **Note:** The greater splanchnic nerve is an *anatomical structure*—a peripheral mixed autonomic/sensory nerve—not a molecular therapeutic target such as a receptor or enzyme. It does not fit standard drug-target classifications used in pharmacology databases; thus "is_target" should be marked false and "is_incorrect" true for purposes where only molecular targets are relevant[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Greater splanchnic nerve.